Advertisement
Screener

Surrozen, Inc./DE (SRZN) ROA

Surrozen, Inc./DE (SRZN) ROA

  • 2026-06-30: ROA -287.29%.
  • 2026-03-31: ROA -283.79%.
  • 2025-12-31: ROA -245.15%.
  • 2025-09-30: ROA -92.41%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-287.29%
2026-03-31-283.79%
2025-12-31-245.15%
2025-09-30-92.41%
2025-06-30-16.26%
2025-03-31-71.15%
2024-12-31-131.15%
2024-09-30-92.58%
2024-06-30-118.59%
2024-03-31-102.34%
2023-12-31-93.41%
2023-09-30-64.67%
2023-06-30-59.09%
2023-03-31-57.08%
2022-12-31-40.26%
2022-09-30-54.88%
2022-06-30-48.83%
2022-03-31-42.13%
2021-12-31-39.84%
2021-09-30-33.54%
2021-06-30-48.56%
2021-03-31-42.22%
2020-12-31-52.72%

Annual ROA

DateROA
2025-12-31-245.15%
2024-12-31-131.15%
2023-12-31-93.41%
2022-12-31-40.26%
2021-12-31-39.84%
2020-12-31-52.72%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zura Bio Ltd (ZURA)$0.398B-6.56
AGENUS INC (AGEN)United States$0.383B1.41
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Eikon Therapeutics, Inc. (EIKN)United States$0.446B